chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Experienced vertigo, nausea, vomiting headache after awaking at approximately 6:00am on 6/7/21.  Outreached PCP and was advised that these events were side effects experienced by some after receiving vaccine.  Ibuprofin was recommended along with rest, fluids, eating small meals, monitoring of symptoms, and was advised by NP for my PCP that symptoms/side effects normally remedy  in 24 to 48 hours.  On the evening of the 48th hour, 1/8/21, after other symptoms had cleared, I began experiencing constant ringing in my left ear and some wobbliness, this continues today 1/11/21.  Called Urgent care and was advised there is nothing they can do for  such symptoms and was advised to continue to receive guidance from PCP.  Am currently awaiting call back from PCP.
At around 9 PM that night I became incredibly tired. I was afflicted with a fever that reached at least 99.9 F. It lasted until about 4 AM that morning.
Fever of 102 F that developed within 12 hours of vaccination and resolved within 24 hours of onset.
On 9/18/98, mom called and said pt was weak, fatigued with a headache, fever and malaise.
Heartburn flush bilateralarms and chest EMS evaluated EKG done sinus tach with PICS. Transport to ER
tingling of the fingertips; some numbness today; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 77-year-old female patient received BNT162b2 (BNT162B2), on 19Jul2022 as dose number unknown (second booster), single (Batch/Lot number: unknown) at the age of 77 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (1 Booster , MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer"), for COVID-19 immunization. The following information was reported: HYPOAESTHESIA (non-serious) with onset Jul2022, outcome "unknown", described as "some numbness today"; PARAESTHESIA (non-serious) with onset 20Jul2022, outcome "not recovered", described as "tingling of the fingertips".  Additional information: Consumer calling in about the Pfizer COVID 19 vaccine. She received the second booster shot Tuesday 19Jul, and started to feel tingling of the fingertips/some numbness today. She wants to know if this is a side effect of the vaccine.She doesn't know if this is from booster or not. She got booster shot this past Tuesday, 19Jul2022, and is noticing tingling in finger tips yesterday and today. Could that be the result of the vaccine. During call, caller stated she has to clear throat. She did not have email for primary care. She did not have date of 1st dose or others and stated she did not have vaccine card with her.  Caller decided she did not have all of the information needed to complete report and requested to be transferred to have her question answered. No further details provided.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Client was given pediatric dose of HBV. No adverse reaction. Phone call made to Imm. Program. They recommended to give adult HBV same day. Client was given adult dose HBV with no adverse event.
Sore left shoulder immediately, Sore left leg hours later Unable to sleep soundly, began to become feverish over night Difficulty moving in the morning, severe aches all over body Specifically my thighs incredibly achy, felt like bones were hot, by the late morning, Took a hot bath to relax, reduce pain, worked, but became very faint Took Tylenol and Ibuprofen, ate lunch, rested, slowly felt better by evening, slept, and was perfectly fine the next morning 48 hours later
After my second booster in March of 2022, in April of 2022 I had a migraine and then two more in May of 2022 and as of today I have up to a total of 8-10 migraines.  I noticed that this was happening after drinking red wine and this had never happened before.  Mid-April 2022 I was having digestive issues with, and it felt like I had a stomach virus.  I took some Tums.  But then after a few days I noticed my bowel movements had changed.  I had a colonoscopy and now my digestive system is somewhat back to normal as before the booster.  In July of 2022 about 2:00am in the morning I woke to go to the restroom.  My heart was racing, and my Apple Watch stated it was 173 bpm.  Within about an hour I realized it was not an emergency, so I waited to go to the emergency room.  I had printed my EKG from my Apple Watch.  The EKG that they did was normal.  I was told that if it happened again, they wanted me to return to the ER.  I am currently wearing a heart monitor and will have results in a few weeks.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 05-NOV-2015 21:02, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L016427, expiry date: 13-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high temperature and low temperature were 10.8 and 2.4 respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
LITTLE ROUGH/PATIENT WAS OFF DUE TO TAKING BOOSTER FOR COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (LITTLE ROUGH/PATIENT WAS OFF DUE TO TAKING BOOSTER FOR COVID-19) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced UNEVALUABLE EVENT (LITTLE ROUGH/PATIENT WAS OFF DUE TO TAKING BOOSTER FOR COVID-19). At the time of the report, UNEVALUABLE EVENT (LITTLE ROUGH/PATIENT WAS OFF DUE TO TAKING BOOSTER FOR COVID-19) had not resolved.            No concomitant medication was reported. On an unknown date, the patient experienced LITTLE ROUGH/PATIENT WAS OFF DUE TO TAKING BOOSTER FOR COVID-19. MODERNA COVID-19 VACCINE (ELASOMERAN) was also considered suspect.  Patient was little rough being off due to taking Booster for covid-19. No treatment medication was reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Causality for RINVOQ(UPADACITINIB): The reporter's causality for the event(s) of LITTLE ROUGH/PATIENT WAS OFF DUE TO TAKING BOOSTER FOR COVID-19 with RINVOQ(UPADACITINIB) was a reasonable possibility.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
On 08/20/2005 the day after the vaccine was given mom noticed red blotches on Pt legs, arms and abdominal area. It was around 7am. then about 10am she saw that there were more than it was 3 hours before.
En el muslo D. parte superior presenta edema, eritema, caliente al tacto, area endureicta.
A really terrible feeling, feeling really sick; Had the worst shivering; Flu-like symptoms; Used a walker; Dizziness; Fatigue; Ready to throw up; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (A really terrible feeling, feeling really sick), CHILLS (Had the worst shivering), INFLUENZA LIKE ILLNESS (Flu-like symptoms), WALKING AID USER (Used a walker) and DIZZINESS (Dizziness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (A really terrible feeling, feeling really sick), CHILLS (Had the worst shivering), INFLUENZA LIKE ILLNESS (Flu-like symptoms), WALKING AID USER (Used a walker), DIZZINESS (Dizziness), FATIGUE (Fatigue) and NAUSEA (Ready to throw up). The patient was treated with GINGER [ZINGIBER OFFICINALE RHIZOME] (GINGER CAPSULE [ZINGIBER OFFICINALE RHIZOME]) for Nausea, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (A really terrible feeling, feeling really sick), CHILLS (Had the worst shivering), INFLUENZA LIKE ILLNESS (Flu-like symptoms), WALKING AID USER (Used a walker), DIZZINESS (Dizziness), FATIGUE (Fatigue) and NAUSEA (Ready to throw up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Heart rate: high (High) 96 BEATS IN SITTING POSITION 105 BEATS FOR SECOND TIME.         Patient could not sleep in any position beacause of pain and also she vaccinated the place where she took small pox vaccine which is in younger
Vertigo that started a few days after the shot has gotten progressively worse over the last two weeks and is ongoing. Metallic taste in mouth for the first two days immediately after the shot.
Plaque psoriasis flare up/break out on back; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Plaque psoriasis flare up/break out on back) and PAIN IN EXTREMITY (Pain in arm) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.   Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis and Psoriatic arthritis.  No Medical History information was reported.  On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Oct-2021, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PSORIASIS (Plaque psoriasis flare up/break out on back) and PAIN IN EXTREMITY (Pain in arm). At the time of the report, PSORIASIS (Plaque psoriasis flare up/break out on back) had not resolved and PAIN IN EXTREMITY (Pain in arm) outcome was unknown.    No concomitant medication information was reported. No treatment medication information was reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Vaccine administration error related to temperature excursion from recommended storage temperature, not known to this writer to be associated with an adverse event The has relayed to this writer that prior to the vaccine's thawing and administration to the vaccine recipient, the administered vaccine was stored in frozen temperatures for longer than recommended by the manufacturer. (This VAERS writer assigned to form completion was not the administrator of this vaccine.)
on march 14th we were alerted that lot FH8028 was stored prior to administration under conditions that departed from the manufacturers recommended specifications.
COVID vaccine (Pfizer) given 5/13/21 and 2nd vaccine given 6/3/21. Both given in L-upper arm.   No urticaria after 1st vaccine. Initially after 2nd vaccine he developed symptoms of tired, fever Tm 101.1 F, upset stomach, headache, body aches, chills and sensation that arms and legs were "numb" about 12 h after vaccine. The "numb" sensation lasted 30 min and no longer present. Denies enlarged lymph nodes, extremity edema.  No hx/o COVID in the past.  Went to Urgent care on 6/7/21 due to full body hives, so given benadryl and topical steroid triamcinolone. It continued to worsen during the day so taken to ER later that day and given Pepcid, steroid IM and benadryl.  Discharged  home on PO prednisone 20mg x 5 days. No Epi was given.  Given benadryl every 6 hours and by the 4 hour mark it would come back. Given zyrtec twice daily 10mg/dose on 6/8/21 evening, 6/9/21 BID. Overnight didn't wake him for benadryl (last dose 8pm). On 6/10/21 given steroid, pepcid and zyrtec and seen by PCP in clinic for ER follow-up. No hives present on exam on 6/10/21 (present the night before). Hives would fade and then come back and were migratory. Hives were pruritic. Also used calamine. Once his lips were swollen, but denies any tongue swelling, itchy throat, cough, wheeze.  Denies N/V/D.  Mother cooked with a new crock pot seasoning at Farmer's market used at dinner the night before the hives developed. Also had strawberry short cake for dessert the night before. The day he had hives he also had strawberries and complained of stomach pain after eating them. No hx/o strawberry allergies or food allergies in the past.  No knew meds, detergents, lotions, soaps prior to hives. No recent illness.
Reported to us: Patient was in and out of emergency room four days after vaccination. He was in a fog or catatonic state. He was on Cipro when 1st dose was administered. He had "places frozen off his face the day before the vaccine."
(R) upper arm has 5cm x 5cm red, swollen circular area where ADACEL was given.
Patient Said About Two Days After She Got Her Booster Pfizer Dose, She Started Experiencing Neuropathy, Tingly, Prickly, Stingy And Burning Sensations All Over Her Arms, Finger Tips, Toes And Legs (Extremities). She Says She Experiences Extreme Cold Or Hot Sensations. She Says Her Symptoms Get Worse At Night.
The morning after the 2nd dose of the COVID vaccine, I woke up with the above symptoms. They are improving with IBProfen and the symptoms did not prevent me from going to work. Fatigue, Headache, injection site pain, malaise and new or worsened muscle pain.
Patient had swelling, redness, and pain in his left arm around injection site. The reaction was already improving, so we recommended benadryl and ibuprofen as needed.
Woke up morning of 1/22/2010 with runny nose and dizziness. Symptoms lasted through 1/23/2010. During the week preceding 1/22, client felt "like she was coming down with something". Took Tylenol. No fever, no redness or swelling at injection site.
About 4 hours after shot I became short of breath  just like when I had Covid-19 this summer. It has gotten better but I am 9 days out and still have to stop occasionally to get my breath. Tiredness.
bad pain in both knees; I am having pain and swelling in the arm pit area on same arm the vaccine was injected.  Feels like a swollen gland.; I am having pain and swelling in the arm pit area on same arm the vaccine was injected.  Feels like a swollen gland.; I am having pain and swelling in the arm pit area on same arm the vaccine was injected.  Feels like a swollen gland.; tested positive for COVID the day after vaccination; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), 1st dose via an unspecified route of administration, administered in arm left on 07Mar2021 16:30 at age of 58 years old as a single dose for COVID-19 immunisation. Medical history included atrial fibrilation, gout. Concomitant medications included flecainide; alopurinol; carvedilol; alfuzosin.  The patient was tested positive for COVID the day after vaccination on 08Mar2021, patient was having pain and swelling in the arm pit area on same arm the vaccine was injected, feels like a swollen gland, all on 08Mar2021 22:00, bad pain in both knees on 11Mar2021 14:30.  The patient underwent lab tests and procedures which included tested for COVID-19: positive (nasal swab) on 08Mar2021, unknown (nasal swab) on 09Mar2021. The outcome of the events was not recovered. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. There had no treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. There had no allergies to medications, food, or other products. List of any other medications the patient had received other medications within 2 weeks of vaccination.   Information on the lot/batch number has been requested.
PATIENT OBTAINED 'SHOT.'  ABOUT 10 MINUTES LATER (SHE) BEGAN TO FEEL CLAMMY  PT STATED THAT SHE MAY HAVE 'BLACKED OUT' A LITTLE - PT HAS A HISTORY OF FAINTING IN EMOTIONAL SITUATIONS
2 1/2 inch round red circle around injection site. Slightly warm and tender day after shot. ? If was a reaction (have had flu shot for 10 years)
Rash arm in same arm as injection; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (pain at injection site) and INJECTION SITE RASH (Rash arm in same arm as injection) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (pain at injection site). On 06-Feb-2021, the patient experienced INJECTION SITE RASH (Rash arm in same arm as injection). On 08-Feb-2021, INJECTION SITE PAIN (pain at injection site) had resolved. At the time of the report, INJECTION SITE RASH (Rash arm in same arm as injection) outcome was unknown. Events for dose 2 of 2      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Hospitalization for COVID on dates 05/04/2022- 05/08/2022.  Treated with vitamin D, zinc, vitamin C, dexamethasone IV.  Didn't meet criteria for Remdesivir.
After receiving high dose influenza vaccine, patient had a reaction that began with mild sniffles and occasional cold-like symptoms for several days.  On November 1, began to have strong flu-like symptoms that have continued for several days.
shingles    taking dexamethasone valacyclovir ibuprofen 600  outcome  still taking meds
Headache, Myalgia. CHILLS, SORE THROAT, TENDERNESS AT SITE Narrative:
Narrative; Per family report, patient died at hospital on 11/18/21. Discovered unresponsive in home on 11/16. Found to be septic secondary to pneumonia with possible stroke. "Not entirely certain of cause of death." Family wanted to draw attention to recent receipt of COVID-19 booster (11/13) in close proximity to this event. As event occurred at hospital, limited records available for review. COVID-19 vaccine dated: 1/30/21, 3/1/21, 11/13/321 (booster)
received on 07-May-2021 a dose that had expired; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a female patient who received HBV (Engerix B) (batch number 4RB3J, expiry date 3rd April 2021) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th May 2021, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 7th May 2021, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The nurse reported that on 7th May 2021, the patient received Engerix B, which was expired on 3rd April 2021. No further information was reported. The reporter consented to follow up.
dizziness; sore throat; allergic reaction; Headache; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 42-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single and received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 08Feb2021 at 10:30 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient had no known allergies. It was reported that after receiving second dose of vaccine on 11Feb2021 at 22:00 pm the patient experienced dizziness, headache and a sore throat and he experienced these after both doses which he believes may be an allergic reaction. His physician has told him to take Benadryl for the next 4 days. Patient had no covid prior vaccination. The adverse event results in doctor or other healthcare professional office/clinic visit. Patient has been tested for covid post vaccination. The patient underwent lab tests and procedures which included nasal swab covid test (sars-cov-2 test) which result was negative and PCR covid test (SARS-CoV-2 test) which result was pending and both tests were on 14Feb2021. The patient was not recovered from the events at the time of report.   Information on batch/lot number was requested.  Follow-up attempts completed. No further information expected.
Caller reported administered MMR II that was improperly stored in the freezer.; This spontaneous report was received from a physician, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported.  On 31-JUL-20, the physician reported that, on an unspecified date, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (rHA) (M-M-R II) injection (lot number S020161 which has been verified to be valid, expiration date reported and validated as 30-JUN-2021) (dosage, vaccination scheme, frequency, route of administration and anatomical site of injection were not reported), as prophylaxis. The administered dose of the vaccine was stored at a temperature of -10 degrees Fahrenheit (F). There was a previous temperature excursion of below 36 F (10 F), during a time frame of 50 minutes, as recorded by a digital data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2008USA001787: US-009507513-2008USA002399: